A high-resolution solution structure of bucandin, a neurotoxin from Malayan krait (Bungarus candidus), was determined by "H-NMR spectroscopy and molecular dynamics. The average backbone root-mean-square deviation for the 20 calculated structures and the mean structure is 0.47 A H (1 A H l 0.1 nm) for all residues and 0.24 A H for the well-defined region that spans residues 23-58. Secondary-structural elements include two antiparallel β-sheets characterized by two and four strands. According to recent Xray analysis, bucandin adopts a typical three-finger loop motif and yet it has some peculiar characteristics that set it apart from other common α-neurotoxins. The presence of a fourth strand in the second antiparallel β-sheet had not been observed before in three-finger toxins, and this feature was well represented in the NMR structure. Although the overall fold of the NMR structure is similar to that of the X-ray crystal structure, there are significant differences between the two structures that have implications for of the ensemble of 20 structures have been deposited in the Research Collaboratory for Structural Bioinformatics (' RSCB ') Protein Data Bank (PDB) under the accession code 1IJC.
INTRODUCTION
The ' three-finger ' loop motif is a common structural feature shared by a family of polypeptide toxins present in many snake venoms. These highly potent toxins are usually 60-75 amino acid residues in length and incorporate 4 or 5 disulphide bridges that stabilize their tertiary structure. Their structures are also characterized by the presence of an anti-parallel β-sheet that spans two neighbouring loops. Despite similarities in overall fold, threefinger toxins have diverse pharmacological functions. Members of this group include α-neurotoxins that block acetylcholine receptors [1] [2] [3] , cardiotoxins that damage cell membranes [4] [5] [6] , fasciculins that inhibit acetylcholine esterase [7] and L-type calcium-channel blockers [8, 9] .
Bucandin is a novel neurotoxin recently isolated from the venom of the Malayan krait (Bungarus candidus). This 63-aminoacid polypeptide enhances the release of acetylcholine from nerve terminals and belongs to a family of three-finger toxins that incorporate five disulphide bridges. Its amino acid sequence has only 30-40 % sequence identity with many three-finger toxins, but it is quite similar to S6C4 toxin from Dendroaspis jamesonii kaimosae [a subspecies of D. jamesonii (Jameson's mamba)] in which 67 % of the amino acid residues are identical.
The structure and pharmacological effects of bucandin are of considerable interest in defining the mode of action of the venom and its possible pharmaceutical uses. The recent atomic-resolution X-ray structure of bucandin shows a highly polar molecule that incorporates two anti-parallel β-sheets [10] . The first loop is isolated from the rest of the molecule, with the tip of the loop twisted away from the rest of the molecule. In the present paper we report a high-resolution structure of bucandin obtained by NMR, as well as details of its separation and purification. The NMR structure is compared in detail with the X-ray structure and with other known three-finger toxins. Additional information on the molecular-dynamical behaviour of bucandin in solution is also presented.
MATERIALS AND METHODS

Materials
Freeze-dried Bungarus candidus venom was obtained from Venom Supplies (Tanunda, SA, Australia). Prepacked columns, Superdex 30 and Nucleosil C ") were purchased from Pharmacia Biotech (Uppsala, Sweden) and Phenomenex (Torrance, CA, U.S.A.) respectively. Reagents for N-terminal amino acid sequencing were from Applied Biosystems (Foster City, CA, U.S.A.). The chromatographic reagents, acetonitrile and TFA were from Fisher Scientific (Fair Lawn, NJ, U.S.A.) and Fluka Figure 1 Purification of bucandin (A) Gel-filtration chromatography of Bungarus candidus venom (150 mg) on a Superdex 30 FPLC column (1.6/60) column. The column was equilibrated and eluted with 50 mM Tris/HCl buffer, pH 7.4, at a flow rate of 1.5 ml/min. The continuous line represents the absorbance at 280 nm, the broken line that at 215 nm and dotted line that at 254 nm. The fraction size was 2 ml. (B) The last peak (indicated by the horizontal bar) from gel-filtration chromatography was further purified on a reverse-phase Nucleosil 5C 18 (2 cmi25 cm) column equilibrated with 0.1 % (v/v) TFA, and the bound proteins were eluted with a linear gradient of 80 % (v/v) acetonitrile in 0.1 % (v/v) TFA at a flow rate of 2 ml/min. Bucandin was isolated from the peak indicated by the arrow. (C) Electrospray-ionisation MS of bucandin. The spectrum shows a series of multiply charged ions, corresponding to a single, homogeneous peptide of molecular mass 7275.4 (inset).
(Buchs, Switzerland) respectively. All other chemicals used were of analytical reagent grade.
Isolation and purification of bucandin
Whole venom (150 mg) was dissolved in 1 ml of MilliQ water and centrifuged at 3000 g for 5 min. The crude venom supernatant was fractionated, on the basis of the molecular masses of the components, on a Superdex 30 FPLC column (1.6 cmi60 cm), using 50 mM Tris\HCl buffer, pH 7.5, at a flow rate of 1.5 ml\ min as eluent. The last peak, containing bucandin, was further purified on a reverse-phase Nucleosil 5 C ") column (2 cmi 25 cm). The column was equilibrated with 0.1 % (v\v) TFA, and the bound proteins were eluted with a linear gradient of 80 % acetonitrile in 0.1 % (v\v) TFA at a flow rate of 2 ml\min.
Electrospray MS
Bucandin was dissolved in acetonitrile\water (1 : 1, v\v) and analysed using a Perkin-Elmer Sciex API 300 triple quadrupole instrument, equipped with an ionspray interface. The ionspray voltage was set at 4600 V and the orifice voltage at 30 V. Nitrogen was used as a curtain gas with a flow rate of 0.6 litres\min, and compressed air was used as the nebulizer gas. The sample was infused into the mass spectrometer at a flow rate of 5 µl\min.
Reduction and pyridylethylation
Bucandin was resuspended in 100 µl of the denaturant buffer (6.0 M guanidinium chloride\0.13 M Tris\1 mM EDTA, pH 8.0) containing 0.07 M β-mercaptoethanol. The solution was heated at 37 mC for 2 h. Subsequently, a 1.5-fold molar excess (over thiol groups) of 4-vinylpyridine was added and incubated at room temperature. After 2 h, the pyridylethylated sample was desalted by reverse-phase HPLC.
N-terminal sequencing
N-terminal sequencing of the native and pyridylethylated protein was done by automated Edman degradation using a Procise 494 pulsed-liquid-phase protein sequencer (PerkinElmer-Applied Biosystems, Foster City, CA, U.S.A.) with an on-line 785A phenylthiohydantoin-amino acid analyser.
NMR spectroscopy
The NMR sample was prepared by All NMR experiments were performed on a Bruker (Karlsruhe, Germany) AVANCE-600 DRX spectrometer using a 5 mm "H inverse probe with operating temperatures of 10, 25 or 35 mC. Two-dimensional (2D) NMR spectra were acquired in the phasesensitive mode using time-proportional phase detection [11] . Homonuclear 2D spectra included double-quantum filtered (DQF-) COSY [12] with the phase-cycle modified for fast recycle times [13] , ECOSY [14] , TOCSY [15] with spin-lock period of 90 ms, and NOESY [16] with mixing times of 100 and 200 ms. Solvent signal-suppression was achieved either by using the WATERGATE pulse sequence [17] or by low-power irradiation at the water resonance frequency. A relaxation delay of 1.3 s between transients was employed in all 2D experiments.
"H-#H exchange experiments were carried out by acquiring a series of 1D experiments for 1 h immediately after reconstituting the freeze-dried sample with #H # O. After this, five 1 h 2D TOCSY experiments were acquired to monitor further the rate of exchange, and to identify better the slowly exchanging amide protons. Backbone amide hydrogen-bond donors were identified as those that were slowly exchanging. Spectra were processed using XWIN-NMR software (Bruker).
Structure calculations
Analysis of 2D spectra was performed using the XEASY program [18] . The NOESY spectrum recorded at 25 mC with a mixing time of 200 ms was chosen for the structural calculations. This ultimately provided 1258 non-redundant upper distance constraints for protons, based on the corresponding cross-peak intensities or volumes. A correction of 0.3 A H was added to all upper-distance bounds to allow for errors in spectral volume integration and conformational averaging.
Analysis of $J NH α coupling constants from 2D NOESY spectra, using the program INFIT [19] , provided 45 φ dihedral angle constraints which were restrained as follows : k120p30m for $J NH α l 8-9 Hz and k120p20m for $J NH α 9 Hz. χ " Dihedral angle constraints and stereospecific assignments of methylene protons for some residues were obtained from the analysis of DQF-COSY, ECOSY and NOESY with 100 ms mixing time [20] . Deviations of p30m were employed in all χ " dihedral angle constraints which were set as either 180 or k60m.
Hydrogen-bonding pairs were deduced from "H-#H exchange experiments, and the preliminary calculated structures. Hydrogen-bonding constraints were only introduced in the final stages of the structure calculations and were assigned upper distance-
The NOAH protocol [21, 22] in the torsion-angle dynamics program DYANA [23] was used in calculating preliminary structures and in assigning non-intra-residue and non-sequential NOESY cross-peaks. A few cycles of NOAH were used to obtain sufficient NOE constraints, after which the standard simulated annealing procedure in DYANA was applied. The disulphide linkages were identified from medium-resolution structures obtained after three rounds of NOAH calculations. These were found to be consistent with those identified earlier [10] and were used as additional constraints in the subsequent structure calculations. In the final structure calculations 6000 DYANA structures were generated from random starting conformations. The ' best ' 120 structures defined as those with the lowest NOE violations, were then refined by simulated annealing with X-PLOR [24] .
The simplified all-hydrogen force field was adopted, and the covalent geometry was constrained using the standard X-PLOR parameters. Details of the structure refinement procedure were given previously [24a] .
RESULTS
Isolation and purification of bucandin
Bucandin was purified to homogeneity by a two-step method as follows. The crude Bungarus candidus venom was separated into seven fractions on a Superdex 30 gel-filtration column ( Figure  1A ). The last protein fraction was eluted after the salt volume of the column. The proteins in this peak were further fractionated on a reverse-phase HPLC column ( Figure 1B ). The major protein peak thus isolated was named bucandin. As shown in Figure  1 
Amino acid sequence and structural similarity of bucandin
We were able to unequivocally identify all the residues and determine the complete amino acid sequence of both native (blank cycles where cysteine residues are found) and pyridylethylated bucandin samples. Bucandin has 63 amino acid residues, including ten cysteine residues (Figure 2A ). The calculated mass is 7275. 24 . With an expected five disulphide bridges,
Figure 3 Amide region of bucandin 1 H NMR NOESY spectrum
Selected medium-and long-range cross-peaks are labelled according to the order of the amino acid residue in the sequence. The 2D spectrum was obtained at 25 mC and pH 3.0.
the calculated mass of 7275.24 coincides well with the measured molecular mass of 7275.43p0.32. Bucandin is similar to neurotoxins, cardiotoxins and other members of the three-finger toxin family. Unlike the most common members of this family, bucandin has the fifth disulphide bridge in the first loop. Figure  2 
Structure determination by NMR
NMR assignments were made by using standard procedures [25] . Bucandin gave excellent 2D spectra with many cross-peaks that were well-dispersed, indicative that β-sheet structures were prevalent in the molecule. The quality of the spectra is exemplified by Figure 3 , where the amide region of the 2D NOESY spectrum is shown. The assignment process was straightforward, since most of the proton resonances of bucandin at 298 K and pH 3.0 were well-resolved and narrow, although some of the peaks overlapped. Problems with the few amide proton peaks that overlapped were readily overcome by adjusting the temperature to give resolved peaks.
The NOAH automatic structure calculation scheme, with 24 cycles, provided highly folded structures that were of medium resolution. The obtained NOE constraints were then checked and were used as reference values in succeeding rounds of NOAH calculations ; at this stage they included dihedral angle and hydrogen-bond constraints. After this, the simulated annealing procedure in DYANA was used to improve the quality of structures by performing an iterative cycle of calculation, structure analysis and constraint revision.
Final structural constraints consisted of 1258 non-redundant inter-proton distances from NOE, 61 dihedral angles and 44 hydrogen bond constraints. NOE constraints were composed of 466 long-range, 130 medium, 257 sequential and 405 intraresidue constraints. The best 120 out of 6000 structures generated in DYANA were subsequently refined by simulated annealing in X-PLOR. The best 20 structures with the lowest total energy were considered as representatives of the bucandin structures. None of these structures had NOE violations greater than 0.2 A H or dihedral-angle violations greater than 2m. A summary of the structural characteristics of the bucandin ensemble is given in Table 1 . PROCHECK analysis [26] of the 20 structures showed that $ 96 % of the non-glycine and non-proline residues lay in the most favoured and ' additionally allowed ' regions of the Ramachandran plot, while $ 3 % resided in the ' generously allowed ' region. Less than 1 % of the residues lay outside the sterically allowed region of the Ramachandran plot. This was due mostly to Ala"*, which was situated in the less-defined region of the structure.
Description of solution structure
The bucandin structure obtained in this NMR study had an overall root-mean-square deviation (RMSD) of 0.47 A H with respect to the mean structure, when the backbones of all residues in the ensemble of 20 structures were superimposed. Figure 4 summarizes the distribution of NOE constraints, RMSD and angular-order parameters for each residue in the ensemble of structures. Clearly, the overall fold is well defined, as shown by the low RMSD values of less than 0.6 A H and backbone angular order parameters greater than 0.90 for most residues. Still, some regions in the molecule were less well defined than others, as shown by their relatively higher angular order-parameter and higher local RMSD values. These included the N-terminus region up to Thr## and the C-terminus region from Asn&*. As shown in Figure 4 (A), the relatively low definition for the N-terminus can be ascribed to the dearth of long-range NOEs for some parts of this region. The RMSD, with respect to the mean structure, decreased to 0.24 A H when only the backbones of residues 23-58 were considered. Figure 5 shows the ensemble of 20 bucandin structures superimposed over the backbone of the well-defined region of residues 23-58. This representation clearly emphasizes the well-defined and less-defined regions of the structures as well as the presence of three distinct loops in the molecule. The welldefined region that spans residues 23-58 incorporates two distinct loops, whereas the less defined region from the N-terminus to Thr## includes the other loop. It is possible that the less welldefined regions that encompass residues 1-22 and 59-63 suggest flexibilities in these parts of the molecule. This, however, cannot be verified using the NOE information alone ; hence further NMR investigation on the local mobility of the bucandin is needed. The bucandin molecule, as shown in Figure 5 , adopts the typical three-finger motif of α-neurotoxins with some peculiar structural characteristics. PROMOTIF analysis [27] of the ensemble of bucandin structures showed that the molecule incorporates two anti-parallel β-sheets with some turns, but no helix. The first sheet has two strands defined by residues 2-5 and 13-16 and is incorporated in the first of the three loops. The second sheet has four strands defined by residues 23-29, 35-40, 46-47 and 51-56 ; this encompasses the second and the third loop. Note that all three-finger toxins known to date have at most three strands in the second β-sheet [1] [2] [3] [4] 6] . The additional strand incorporating residues 46-47 is therefore unique to the bucandin structure. The presence of this distinct structural element was clearly supported by the NMR data, as summarized in Figure 6 . The "H-#H exchange experiment, for example, showed that the amide of Ile%' and Thr%) were slow-exchanging and were therefore inferred to be hydrogen-bonded to the carbonyl group of Asn&$ and Val&" respectively. Moreover, the chemical-shift index [28] of j1 and $J NH α coupling constants greater than 8 Hz for residues 46-48 also suggested that they were most likely involved in a β-strand.
The first loop in the bucandin molecule is distinct from the rest of the molecule and is orientated at an angle of $ 45m with respect to the second and third loops. This loop incorporates the first βsheet that is twisted, and a disulphide pair that stabilize the loop. There are two kinks near the two cysteine residues, thus causing the end of the loop to be directed away from the rest of the molecule. Although the loop spanning residues 1-22 is flexible, it is well-defined locally, with an RMSD of 0.49 A H with respect to the mean structure. The turn defined by residues 18-21, situated at the base from which the three loops originate, shows a lack of definition, which implies higher mobility. The rest of the molecule, which includes the second and third loops, is probably stabilized by the four-stranded β-sheet and is therefore more rigid.
The conformations of the Cys'-Cys"" and Cys%$-Cys&& disulphide bridges were well defined in the ensemble of 20 structures with dihedral angle χ ss values of k116p5m and 68p4m. The Cys$-Cys#% and Cys"(-Cys$* disulphide bonds were moderately well defined, with χ ss values of k131p35m and k35p34m respectively, while that of Cys&'-Cys'" was poorly defined, with a χ ss value of k25p58m. The lack of definition in the flexible Cterminal region is responsible for the large deviation in the χ ss of the Cys&'-Cys'" disulphide bond.
Overall, bucandin is a relatively flat molecule, with the two anti-parallel β-sheets lying almost on the same plane (see Figure  5B ). Thus it has two distinct faces, face A and face B, that are probably important for its effective interaction with its target molecule(s). The front face (face A) contains a distinct hydrophobic region near the centre, while the other face (face B) is largely positive in charge and may therefore associate with the cell membrane. The clear separation between the hydrophobic and hydrophilic portions of bucandin indicates an amphipathic molecule that may easily penetrate cell membranes and thus exert its biological effect(s) intracellularly.
DISCUSSION
In the present study we determined the high-resolution structure of bucandin in aqueous solution. The ' quality ' of the obtained structure is found to be better than many of the reported threefinger toxin solution structures to date [29] [30] [31] . This favourable outcome was primarily due to the excellent quality of its 2D NOESY spectra, which yielded numerous cross-peaks. It is therefore relevant to compare this high-quality solution structure with the recently obtained high-resolution X-ray structure and also with structures of other common three-finger toxins.
Comparison with X-ray structure Figure 7 (A) presents the NMR and X-ray structures superimposed over the backbone atoms of all residues. Overall, the NMR structure has good correlation with the X-ray structure. An RMSD of 1.37 A H was obtained when the backbone atoms of all the residues were superimposed ; this decreased to 0.94 A H when only the residues in the β-sheets were superimposed. Note that even the first loop, which shows some degree of mobility in the NMR structure, is well superimposed on the X-ray structure.
The secondary-structural elements, such as β-strands and turns, found in the crystal structure are also present in the NMR structure ; however, there are differences in their extent. In the X- [28] . Any dense grouping of 1's, such as three or more 1's uninterrupted by k1's, is suggestive of the presence of β-strand. The locations of expected β-strands in the sequence are marked by the hatched horizontal bars. ray structure, β-strands are claimed to span residues 1-5, 13-17, 23-28, 35-39, 45-48 and 51-57, whereas, in the NMR structure, β-strands extend over residues 2-5, 13-16, 23-29, 35-40, 46-47 and 51-56. Our analysis of the X-ray structure using MOLMOL [32] showed that the extent of the second β-sheet was identical with that in the NMR structure ; however, the first β-sheet was found to contain a β-bulge and was considerably longer, spanning residues 2-7 and 10-16 (see Figures 7B and 7C) .
The most significant difference in the backbone fold of the two structures is situated in the region spanning residues 42-49, where an RMSD of 1.37 A H was obtained. Note that this region in the molecule includes the fourth β-strand, defined by residues 46-47, that is found to be unique to bucandin. In the NMR structure, this short strand is situated on the side of the two faces and is slightly offset from the plane defined by the three strands of the second β-sheet. In the X-ray structure, the β-strand is longer, spanning residues 45-48 and is oriented basically on the same plane as the second β-sheet [10] .
Further comparisons of the solution and crystal structures also show that there are significant differences in orientations of some side chains ( Figures 7B and 7C) . It is clear that, although the dispositions of many of these side-chain residues are alike, those of Trp#( and Trp$', located on the lower portion of the middle loop, are different. These two side chains are highly defined in the NMR structures, with angular-order parameters (χ") $ 1.0 (see Figure 4E ). The side chains of Trp#( and Trp$' are definitely closer in the solution structure than they are in the crystal structure, so that the resulting hydrophobic patch is closer to the tip of the second loop in the NMR structure. Considering that both solution and crystal structures are of high resolution, one can surmise that the small deviations are real and are probably due to the difference in the molecular environments in which the structures were determined ; these include differences in pH, temperature and the presence of intermolecular packing interactions in crystals.
Comparison with other three-finger toxin structures
The most extensive sequence similarity between bucandin and other toxins is the 73 % similarity to S6C4, a toxin isolated from D. j. kaimosae. Unfortunately, little is known about this toxin's mode of action or its structure, so a detailed comparison with bucandin is not possible. The other three-finger toxins with similar five-disulphide-bond arrangements have only $ 30-40 % sequence identity with bucandin, and these include the ten cysteine residues that constitute about half of the identical residues. Since bucandin shares a similar folding pattern with these types of toxin, this suggests that the five disulphide bonds play a central role in determining and maintaining this rigid structural motif. Other similar residues which are likely to be important for the structural configuration include Leu \ Met " , Thr"', Glu#", Phe \ Tyr #& , Lys#', Arg$&, Gly$), Ala%!, Thr%#, Ser \ Thr &( , Thr&), Asp \ Asn &* and Asn'#. In comparison with three-finger toxins that have only four disulphide bonds, conserved residues in bucandin, including Tyr#&, Gly$), Thr&), Asn&* and Asn'#. Tyr#& and Gly$) are situated on face A at the centre of the molecule, whereas Thr&), Asn&* and Asn'# are found on the C-terminus. Figure 8 compares our calculated structure of bucandin with those of selected three-finger toxins : cobratoxin, erabutoxin and cytoxin II. The strong similarities in overall folds, as well as variations in configurations among the four molecules, are clearly highlighted in the Figure. Note that Tyr#&, situated at the centre of the middle loop, is specifically conserved in the four molecules and has its side chain oriented in the same manner. The side chain of this residue is well defined in the NMR structure with χ" l 0.99, as illustrated in Figure 4 (E).
Studies on α-neurotoxins, such as cobratoxin and erabutoxin, show that the functional residues responsible for their toxicities are situated mainly on the lower half of the second and third loops, located on the front face (face A) of the molecule [33] . The tips of the loops are flexible and usually contain some of the functionally important side chains. The upper half of the loop on the front face, on the other hand, contains a hydrophobic patch or centre, which includes a conserved tyrosine residue (Tyr#&) that is believed to be important for the stability of the antiparallel β-sheet structure.
Similar distribution patterns of structural and functional residues are seen in the cytotoxins (cardiotoxins) ; they contain alternating hydrophobic and hydrophilic bands that surround the molecules from the core to the tips of the loop [6] . Hydrophobic side chains, believed to be important for interaction with the lipid part of a cell membrane, occupy the tip of the three loops while the middle part, which is essentially hydrophilic, contains the structurally important tyrosine residue (Tyr#&). It is hypothesized that the composition of the tip of the second loop determines the specificity of different cytotoxins. As shown in Figure 8(A) , the tips of the three loops in bucandin are not hydrophobic overall, although the tips do contain one hydro-phobic residue in each loop (Val), Ile$" and Trp%* respectively). This structural characteristic alone suggests that bucandin is not a cytotoxin (cardiotoxin).
Even erabutoxin has a hydrophilic band in the middle of the molecule ; this is similar to that found in cytotoxins, whereas cobratoxin only has a hydrophilic region in face A. It has been speculated that such a hydrophilic band, which is essentially basic, in cytotoxins could easily interact with the negatively charged surface of cell membranes [34] . The clear separation of the basic and hydrophobic parts of cytotoxins allows for a more specific interaction with membranes, which in turn causes cell disruption, leading to depolarization and cell lysis.
Bucandin does not have a hydrophilic band in the middle of its structure. There is a continuous positively charged region in face B, but this hydrophilic region is interrupted by the large hydrophobic patch in face A that is defined by Tyr#&, Trp#(, Trp$', Ala%!, Ile%' and Val&". In the crystal structure, the three aromatic side chains of Tyr#&, Trp#( and Trp$' are almost evenly distributed, forming a continuous patch that extends the second β-sheet from Ala%! to Ile%'. In the NMR structure, the side chains of Trp#( and Trp$' are stacked together and are directed towards the lower end, in essence isolated from the structurally important Tyr#&. Considering the structural and functional studies of αneurotoxins and cytotoxins, as mentioned above, the two Trp residues located on the lower end of the second loop are likely to be important for the activity of this toxin.
On the basis of the structure alone, it is difficult to speculate whether bucandin is an α-neurotoxin or not, owing to the diversity of side chains found in many of these type of molecules. Note, however, that there are aspects of the bucandin structure that set it apart from other known three-finger toxin structures. The most apparent, as mentioned above, is the presence of the fourth strand, spanning residues 46-47 in the second antiparallel β-sheet. This distinct region in bucandin is highly acidic, owing to the presence of Glu%& and Asp%(, whose side chains point outwards, towards the solvent and parallel with the plane of the molecule. On the opposite side, basic side chains of Arg&, His"# and Lys"% are lined up along the edge of the second strand of the first β-sheet. These, together with basic residues in the middle of face B, make the bucandin molecule highly polar, with the vector of its dipole moment pointing towards the very negatively charged first loop [10] .
We have presented here a high-resolution NMR structure of bucandin, a novel neurotoxin that enhances acetylcholine release from nerve terminals. The structure obtained in solution had some distinct differences from that obtained in crystals, although the overall folds are similar. The NMR study found that the first loop, which includes the two-stranded β-sheet and the C-terminus of bucandin, could probably have higher degrees of flexibility than the rest of the molecule. The low sequence similarity of bucandin with other known three-finger toxins provides useful insights into functionally and structurally important side chains in this polypeptide toxin.
